Business Wire

Neustar: DDoS Attacks Increase 180% in 2019 Compared To 2018

26.3.2020 11:00:00 EET | Business Wire | Press release

Share

Neustar, Inc., a global information services and technology company and leader in identity resolution, announced that its Security Operations Center (SOC) saw a 168% increase in distributed denial-of-service (DDoS) attacks in Q4 2019, compared with Q4 2018, and a 180% increase overall in 2019 vs. 2018. According to Neustar’s latest cyber threats and trends report, released today, the company saw DDoS attacks across all size categories increase in 2019, with attacks sized 5 Gbps and below seeing the largest growth. These small-scale attacks made up more than three quarters of all attacks the company mitigated on behalf of its customers in 2019.

DDoS attacks taking varied forms
In 2019, the largest threat Neustar mitigated, at 587 gigabits per second (Gbps), was 31% larger than the largest attack of 2018, while the maximum attack intensity observed in 2019, 343 million packets per second (Mpps), was 252% higher than that of the most intense attack seen in 2018. However, despite these higher peaks, the average attack size (12 Gbps) and intensity (3 Mpps) remained consistent year over year. The longest single, uninterrupted attack experienced in 2019 lasted three days, 13 hours and eight minutes.

Though the number of attacks increased significantly across all size categories, small-scale attacks (5 Gbps and below) again saw the largest growth in 2019, continuing the trend from the previous year. The combination of DDoS-for-hire and botnet rental services has made DDoS attacks much easier to execute, but the fact that perpetrators seem to be in many cases choosing to engage in small-scale attacks suggests that their goal may often be something other than taking a site completely offline.

“Large, headline-making DDoS attacks do still take place, but many cybersecurity professionals believe that smaller attacks are being used simply to degrade site performance or as a smokescreen for other forms of cybercrime, such as data theft or network infiltration, which the perpetrator can execute more easily while the target’s security team is busy fighting a DDoS attack,” said Rodney Joffe, senior vice president, senior technologist and fellow at Neustar. “Furthermore, with the current move of the bulk of the workforce globally to a work from home model, we expect to see a significant increase in DDoS attacks against VPN infrastructure. This risk makes an ‘always on’ DDoS mitigation service even more critical.”

In addition to conventional DDoS attacks, which seek to exhaust bandwidth, in 2019 Neustar also observed an increase in network protocol or state exhaustion attacks, which target network infrastructure directly. Volumetric attacks continued to proliferate as well, with attackers using new DDoS vectors such as Apple Remote Management Services, Web Services Dynamic Discovery, Ubiquiti Discovery Protocol and the Constrained Application Protocol.

Said Joffe, “During the shift to teleworking at scale, we would not be surprised to see the VPN protocol ports added to these targeted attacks.”

Two- and three-vector attacks ‘just right’ for attackers
In 2019, approximately 85% of all attacks used two or more threat vectors. That number is comparable to the 2018 figure; however, the number of attacks involving two or three vectors rose from 55% to 70%, with correspondingly fewer simple single-vector attacks and complex four- and five-vector attacks, suggesting that attackers have settled into the Goldilocks zone for attacks.

Security professionals continue to view DDoS attacks as a growing threat. According to the most recent Neustar International Security Council (NISC) survey, when asked which vectors they perceived to be increasing threats during November and December 2019, senior-level cybersecurity decision-makers cited social engineering via email most frequently (59%), followed by DDoS (58%) and ransomware (56%).

Web attacks increasing
2019 saw web attacks on the rise as well. Most companies recognise the danger that slow-loading websites pose to their business and attempt to protect them with web application firewalls. In the most recent NISC survey, 98% of respondents agreed that a WAF was an essential component of their security infrastructure. However, as more and more enterprises use multiple cloud providers, often involving a mix of public and private clouds, the need for consistent security across applications and platforms is growing.

“Web attacks can be difficult to track because some variation in the performance of websites is to be expected, but they are increasingly critical for businesses to address. One survey found 45% of consumers are less likely to make a purchase when they experience a slow loading website, and 37% are less likely to return to a retailer if they experience slow loading pages,” added Joffe.

A vendor-neutral cloud WAF, coupled with DDoS protection, can eliminate a large portion of threats, allowing enterprise application experts to focus their attention on the more specialised attacks. Continuous updates from a reliable threat feed can also deliver information on bad IPs and botnet command and control (C&C) sites before they are able to damage the network.

A complimentary copy of the Neustar 2019: The Year in Review cyber threats and trends report is available here.

-ENDS-

About Neustar
Neustar is an information services and technology company and a leader in identity resolution providing the data and technology that enables trusted connections between companies and people at the moments that matter most. Neustar offers industry-leading solutions in Marketing, Risk, Communications, Security and Registry that responsibly connect data on people, devices and locations, continuously corroborated through billions of transactions. Neustar serves more than 8,000 clients worldwide, including 60 of the Fortune 100. Learn how your company can benefit from the power of trusted connections here: https://www.home.neustar.

# # #

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Jenny Morris
Hotwire for Neustar
+44 (0)7393465529
neustaruk@hotwireglobal.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

OCP Announces Date of Second Quarter and First Half 2026 Earnings22.9.2026 17:00:00 EEST | Press release

OCP S.A. (“OCP” or the “Company”), a global leader in the fertilizer industry, will release its second quarter and first half 2026 results on Tuesday, September 29, 2026. The results will be available to holders of the Company’s bonds, qualified institutional buyers, securities analysts and market makers on the OCP Intralinks portal from 10:00 a.m. EDT, 2:00 p.m. Morocco (GMT) and 3:00 p.m. London time (GMT+1). OCP senior management will host a conference call to discuss second quarter and first half 2026 results at 11:00 a.m. EDT, 3:00 p.m. Morocco (GMT) and 4:00 p.m. London time (GMT+1) on Tuesday, September 29, 2026, for holders of the Company’s bonds, qualified institutional buyers, securities analysts and market makers. Eligible parties that have not already registered for access to the Intralinks portal may do so by contacting the Investor Relations Department by emailing g.laraki@ocpgroup.ma. About OCP OCP is a global leader in the fertilizer industry, backed by almost a century

Takeda Highlights Late-Stage Oncology Pipeline Progress and Solid Tumor Portfolio Research, Led by Late-Breaking Phase 3 Arcotatug Tavatecan (TAK-921) Data, at ESMO 202622.9.2026 16:30:00 EEST | Press release

Takeda(TSE:4502/NYSE:TAK)announced that new data from its oncology pipeline and portfolio will be presented at the European Society for Medical Oncology (ESMO) Congress, taking place October 23-27, 2026, in Madrid, Spain. Key data will include a late-breaking abstract on arcotatug tavatecan (TAK-921; Innovent R&D code: IBI343*) and two presentations on TAK-928 (Innovent R&D code: IBI363*). Clinical and real-world analyses of ALUNBRIG® (brigatinib) and FRUZAQLA® (fruquintinib) will also be shared at the congress. “Takeda’s data at ESMO reflect our commitment to delivering rapid progress for patients living with some of the most prevalent and challenging cancers, including advanced gastric cancer and immunotherapy-resistant and previously untreated non-small cell lung cancer,” said Phuong Khanh (P.K.) Morrow, M.D., Head of the Oncology Therapeutic Area Unit at Takeda. “Our mission is to advance new therapeutic approaches for patients who need more options or who remain underserved by cur

Quaise Energy Selected for Up to $25 Million in U.S. Department of Energy Support to Advance World's First Commercial Superhot Geothermal Power Plant22.9.2026 16:30:00 EEST | Press release

Quaise Energy, a leading developer of utility-scale superhot geothermal energy, today announced that it has been selected by the U.S. Department of Energy (DOE) for up to $25 million in funding under the Next-Generation Geothermal Field Tests and Geothermal Resource Characterization and Confirmation funding opportunity. The support brings the U.S. closer to commercializing superhot Enhanced Geothermal Systems — technology that could unlock firm, clean power from hot rock beneath virtually any geography in the country. The funding will advance Project Obsidian, the world's first commercial superhot geothermal power plant, in Central Oregon. It will support analysis of the drilling, stimulation, and flow results of the first two wells to optimize a third well at the Obsidian site. The three-well configuration is targeting average reservoir temperatures of over 300°C and is designed to demonstrate more than 25 megawatts of gross electric power capacity. The DOE funding will also enable Qu

From CSR to Public Health Impact: How Colgate Bright Smiles, Bright Futures® is Driving Behavior Change for the Next Billion Children and Their Families22.9.2026 16:00:00 EEST | Press release

Colgate-Palmolive, the worldwide leader in oral care, announced a strategic evolution in its flagship oral health education program, Colgate Bright Smiles, Bright Futures® (BSBF), reflecting the Company’s commitment to global public health. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260922129016/en/ Launched in 1991, the program has reached over two billion children and their families across more than 100 countries, demonstrating how private-sector commitment designed to support communities, can become a powerful force for public health, driving healthier behaviors and positive outcomes at scale. From health education curriculum and school programming to mobile dental vans and free oral health screenings, BSBF helps children and their families access care, adopt healthier habits, and improve long-term oral health outcomes. “At Colgate-Palmolive, we believe oral health and healthier, brighter futures are inextricably link

Incyte Data at the European Academy of Dermatology and Venereology (EADV) Congress Underscore the Breadth of Incyte’s Inflammation and Autoimmunity Portfolio22.9.2026 15:30:00 EEST | Press release

Incyte (Nasdaq:INCY) today announced that data from across its Inflammation and Autoimmunity (IAI) portfolio will be presented at the European Academy of Dermatology and Venereology (EADV) 2026, held September 30 - October 3, 2026, in Vienna, Austria. "The breadth of research being presented at EADV 2026 highlights the strength of our Inflammation and Autoimmunity portfolio," said Pablo J. Cagnoni, M.D., President, Incyte and Global Head of Research and Development. "Data presentations in hidradenitis suppurativa, atopic dermatitis and prurigo nodularis demonstrate our commitment to advancing innovation across immune-mediated skin diseases and deepening our understanding of the patient experience." Details on key Incyte data presentations at EADV include: Oral Presentations Atopic Dermatitis Atopic Dermatitis and Life Course Disruption: Evidence From a Multidimensional International Survey (TOPiQAL) (Session: Free Communication 1: Atopic dermatitis/Eczema. Thursday, October 1, 2:50-3:0

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye